These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29944734)

  • 1. Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?
    Puccetti M; Ravaioli S; Tumedei MM; Bucchi E; Malmesi M; Medri L; Bravaccini S
    Histopathology; 2018 Nov; 73(5):801-808. PubMed ID: 29944734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast cancer FNA cell blocks and paired histologic specimens: A large retrospective study.
    Vohra P; Buelow B; Chen YY; Serrano M; Vohra MS; Berry A; Ljung BM
    Cancer Cytopathol; 2016 Nov; 124(11):828-835. PubMed ID: 27315045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytological evaluation of biological prognostic markers from primary breast carcinomas.
    Makris A; Allred DC; Powles TJ; Dowsett M; Fernando IN; Trott PA; Ashley SE; Ormerod MG; Titley JC; Osborne CK
    Breast Cancer Res Treat; 1997 May; 44(1):65-74. PubMed ID: 9164679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance between core needle biopsy and surgical specimen for oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 status in breast cancer.
    Asogan AB; Hong GS; Arni Prabhakaran SK
    Singapore Med J; 2017 Mar; 58(3):145-149. PubMed ID: 27029805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of molecular subtypes classification concordance between preoperative core needle biopsy and surgical specimen on early breast cancer management: Single-institution experience and review of published literature.
    Meattini I; Bicchierai G; Saieva C; De Benedetto D; Desideri I; Becherini C; Abdulcadir D; Vanzi E; Boeri C; Gabbrielli S; Lucci F; Sanchez L; Casella D; Bernini M; Orzalesi L; Vezzosi V; Greto D; Mangoni M; Bianchi S; Livi L; Nori J
    Eur J Surg Oncol; 2017 Apr; 43(4):642-648. PubMed ID: 27889196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cost-effectiveness of fine needle aspiration biopsy versus image-guided biopsy, and open surgical biopsy in the evaluation of breast cancer in the era of Affordable Care Act: a changing landscape.
    Masood S; Rosa M; Kraemer DF; Smotherman C; Mohammadi A
    Diagn Cytopathol; 2015 Aug; 43(8):605-12. PubMed ID: 25722099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xpert Breast Cancer STRAT4 Assay using fine-needle aspiration biopsy samples in a resource-constrained setting: a prospective diagnostic accuracy study.
    Ng DL; Vuhahula E; Kimambo AH; Ndayisaba MC; Philipo GS; Mushi BP; Ho KE; Paciorek A; Illonga Z; Zhang L; Vohra P; Weidler J; Bates M; Mmbaga EJ; Van Loon K
    Lancet Oncol; 2024 Nov; 25(11):1440-1452. PubMed ID: 39369731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemistry for oestrogen receptor, progesterone receptor and HER2 on cell blocks in primary breast carcinoma.
    Kumar SK; Gupta N; Rajwanshi A; Joshi K; Singh G
    Cytopathology; 2012 Jun; 23(3):181-6. PubMed ID: 21375607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas.
    Nizzoli R; Bozzetti C; Naldi N; Guazzi A; Gabrielli M; Michiara M; Camisa R; Barilli A; Cocconi G
    Cancer; 2000 Feb; 90(1):61-6. PubMed ID: 10692218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast fine needle aspiration continues to be relevant in a large academic medical center: experience from Massachusetts General Hospital.
    Dong J; Ly A; Arpin R; Ahmed Q; Brachtel E
    Breast Cancer Res Treat; 2016 Jul; 158(2):297-305. PubMed ID: 27383478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large-core needle biopsy versus fine-needle aspiration biopsy in solid breast lesions: comparison of costs and diagnostic value.
    Vimpeli SM; Saarenmaa I; Huhtala H; Soimakallio S
    Acta Radiol; 2008 Oct; 49(8):863-9. PubMed ID: 18618302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients.
    Chen X; Zhu S; Fei X; Garfield DH; Wu J; Huang O; Li Y; Zhu L; He J; Chen W; Jin X; Shen K
    BMC Cancer; 2015 Oct; 15():822. PubMed ID: 26514283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of breast cancer surrogate subtyping using a closed-system RT-qPCR breast cancer assay and immunohistochemistry on 100 core needle biopsies with matching surgical specimens.
    Janeva S; Parris TZ; Nasic S; De Lara S; Larsson K; Audisio RA; Olofsson Bagge R; Kovács A
    BMC Cancer; 2021 Apr; 21(1):439. PubMed ID: 33879115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of immunocytochemistry and fluorescence in situ hybridization on fine-needle aspiration cytology samples of breast cancers: A comparative study.
    Acs B; Szekely N; Szasz AM; Lotz G; Szekely T; Istok R; Szekely E; Madaras L; Kulka J; Jaray B
    Diagn Cytopathol; 2016 Jun; 44(6):466-71. PubMed ID: 26990933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status in Breast Carcinoma Using Thin-Prep Cytology Fine Needle Aspiration Cytology FISH Experience From China.
    Zhang Z; Yuan P; Guo H; Zhao L; Ying J; Wang M; Zhao H; Pan Q; Xu B
    Medicine (Baltimore); 2015 Jun; 94(24):e981. PubMed ID: 26091472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of Ki67 analysed by cytology or histology in primary breast cancer.
    Robertson S; Stålhammar G; Darai-Ramqvist E; Rantalainen M; Tobin NP; Bergh J; Hartman J
    J Clin Pathol; 2018 Sep; 71(9):787-794. PubMed ID: 29588372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of breast carcinoma prognostic/predictive biomarkers on cell blocks obtained by various methods: Cellient, formalin and thrombin.
    Gorman BK; Kosarac O; Chakraborty S; Schwartz MR; Mody DR
    Acta Cytol; 2012; 56(3):289-96. PubMed ID: 22555532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Estrogen Receptor Immunohistochemistry on Cell Blocks From Breast Cancer Patients in a Low-Resource Setting.
    Kimambo AH; Vuhahula EA; Mwakigonja AR; Ljung BM; Zhang L; Van Loon K; Ng DL
    Arch Pathol Lab Med; 2021 Jul; 145(7):834-841. PubMed ID: 33053150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell Block-Based Two-Dimensional and Immunocytochemical Analyses Could Reduce Atypical/Indeterminate Case Frequency in Breast Fine-Needle Aspiration Cytology: A Retrospective Analysis.
    Noda Y; Nakanishi Y; Tsuta K; Inaji H; Yamasaki M
    Acta Cytol; 2023; 67(6):583-592. PubMed ID: 37820610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.